The Pertussis (Whooping Cough) drugs in development market research report provides comprehensive information on the therapeutics under development for Pertussis (Whooping Cough), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Pertussis (Whooping Cough). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued products.
GlobalData tracks 45 drugs in development for Pertussis (Whooping Cough) by 30 companies/universities/institutes. The top development phase for Pertussis (Whooping Cough) is preclinical with 15 drugs in that stage. The Pertussis (Whooping Cough) pipeline has 40 drugs in development by companies and five by universities/ institutes. Some of the companies in the Pertussis (Whooping Cough) pipeline products market are: Serum Institute of India, Butantan Institute and AIM Vaccine.
The key targets in the Pertussis (Whooping Cough) pipeline products market include Pertussis Toxin, Tetanus Toxin, and Diphtheria Toxin.
The key mechanisms of action in the Pertussis (Whooping Cough) pipeline product include Pertussis Toxin Inhibitor with one drug in Preclinical. The Pertussis (Whooping Cough) pipeline products include three routes of administration with the top ROA being Intramuscular and nine key molecule types in the Pertussis (Whooping Cough) pipeline products market including Toxoid Vaccine, and Vaccine.
Pertussis (Whooping Cough) overview
Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red watery eyes, and dry cough. Treatment includes antibiotics.
For a complete picture of Pertussis (Whooping Cough)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
